|
415 OFT decides to
scrutinise UK medicines distribution Distribution
of medicines in the UK and, in particular, the direct-to-pharmacy model
being increasingly pursued by manufacturers will be scrutinised by the
Office of Fair Trading, the consumer watchdog announced last week
PJ 2007;278:415
Full Text
415 PSNC and NPA to discuss possibility
of a future merger Exploratory talks over
a possible merger between the Pharmaceutical Services Negotiating Committee
and the National Pharmacy Association are to be held. Neither organisation
has decided that a merger is a good idea, just that talks should be held
PJ 2007;278:415
Full Text
416 Financial stability for
last phase of Scottish contract Keeping existing
transitional remuneration arrangements in place will provide stability so that
community pharmacists in Scotland can prepare for the introduction of the remainder
of their new contract, the Scottish Pharmaceutical General Council said this
week
PJ 2007;278:416
Full Text
416 £9.5m patient safety boost as new research centres established Two
expert research centres have been established to drive improvements in the safety,
quality and effectiveness of NHS services
PJ 2007;278:416
Full Text
416 Bids sought by GMC for doctors' prescribing
errors research Funding for a £100,000 research project to investigate the prevalence and causes of prescribing errors made by newly qualified doctors has been announced by the General Medical Council
PJ 2007;278:416
Full Text
416 New wave of community hospitals announced Successful bids for a £50m wave of new community hospitals and super-surgeries, three of which feature pharmacies, were announced this week by health minister Andy Burnham
PJ 2007;278:416
Full Text
417 King’s Fund report
reveals support for royal college There is strong
support in the profession for establishing a royal college for pharmacy to replace
the current fragmented structure but there are concerns that it should not be
a rebadged version of the Royal Pharmaceutical Society, according to a King's
Fund report published last week
PJ 2007;278:417
Full Text
417 Students want to be involved in new professional
leadership body The British Pharmaceutical Students'
Association should be involved
in shaping the professional leadership body formed as part of the Government's
proposed changes to the regulation of health professionals, members of the BPSA
believe
PJ 2007;278:417
Full Text
417 Stoma reimbursement changes criticised FProposed
changes to the reimbursement of stoma and incontinence supplies in England will
exacerbate the problem of products having to be dispensed at a loss, the Pharmaceutical
Services Negotiating Committee has warnedour
PJ 2007;278:417
Full Text
417 UniChem leaves BAPW over wholesale rift UniChem
this week terminated its membership of the British Association of Pharmaceutical
Wholesalers over differences relating to UniChem's distribution deal with Pfizer
PJ 2007;278:417
Full Text
418 Opportunistic chlamydia
screening evidence lacking There is little evidence
to support opportunistic chlamydia screening, as offered by the national chlamydia
screening programme in England, it is argued
PJ 2007;278:418
Full Text
418 Darunavir efficacy is promising at 48 weeks Darunavir
(Prezista), a new protease inhibitor for HIV patients, has shown promising results
in phase II trials comparing it with control protease inhibitors in treatment-experienced
patients
PJ 2007;278:418
Full Text
418 Ofsted now responsible for medicines in
children's homes Responsibility for ensuring that
children's medicines needs are met in care homes has been transferred from the
Commission for Social Care Inspection to Ofsted
PJ 2007;278:418
Full Text
418 Statin link to lower sepsis risk Statin
therapy is associated with reduced risk of sepsis in patients with end-stage
renal disease
PJ 2007;278:418
Full Text
418 DoH 2007–08 work plan The
Department of Health is developing a Health and Social Care Bill, which will
deal with NHS pharmaceutical services, among other matters
PJ 2007;278:418
Full Text
418 Date rape drugs to be classified The
Advisory Council on the Misuse of Drugs is expected to recommend the classification
of date rape drugs gamma-buterolactone and 1,4-butanediol
PJ 2007;278:418
Full Text
419 Medical treatment matches
coronary intervention Optimal medical therapy is
as effective as percutaneous coronary intervention (PCI) in reducing the risk
of death, myocardial infarction and other major cardiovascular events in patients
with stable coronary artery disease, according to a prospective study that is
predicted to change practice
PJ 2007;278:419
Full Text
419 YPG pharmacy plans coming to fruition after
five years Plans announced five years ago by the
Young Pharmacists Group to open a model pharmacy to show how to maximise, develop
and build on current opportunities are expected to come to fruition in the summer
PJ 2007;278:419
Full Text
419 Charity funds pharmacist in primary care A
specialist pharmacist, Anna Hodgkinson, has been appointed with funding from
the British Heart Foundation to help care for patients with heart failure in
London
PJ 2007;278:419
Full Text
419 DoH extends choice Patients
are to be allowed to book their own hospital appointments online at public libraries
in 10 areas of England as part of the Department of Health's plans to widen choice
PJ 2007;278:419
Full Text
419 Rosuvastatin does not lead to regression
of atherosclerosis Patients receiving rosuvastatin
(Crestor) experience reduced progression of carotid atherosclerosis compared
with those taking placebo, but not a regression of disease, a recent study shows
PJ 2007;278:419
Full Text |
The
Pharmaceutical Journal